Friday, May 4, 2012

Codexis pharma enzymes boost revenue

Federal approval to manufacture an ingredient used in a popular drug for diabetics means Codexis Inc. has another revenue source. The company develops industrial enzymes for the production of pharmaceuticals, biofuels and biobased chemicals, and pharmaceuticals have become a major portion of the company’s revenue.

No comments:

Post a Comment